Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-06 | New | $75,000 | $75,000 | Debt Only | 06b | SEC link |
| 2022-03-29 | New | $2,440,568 | $2,440,568 | Equity Only | 06b | SEC link |
| 2015-04-15 | New | $400,000 | $400,000 | Equity Only | 06b | SEC link |
| 2013-02-14 | New | Yet to Sell | $0 | Equity Only | 06 | SEC link |
| 2012-03-20 | New | Yet to Sell | $0 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Jeffrey Bluestein | Director |
| David Dantzker | Director |
| Eliot Davidowitz | Director, Executive |
| Douglas Durand | Director |
| William Erhardt | Director, Executive |
| Robert Foerster | Director, Executive |
| Robert Forester | Executive |
| Victor Micati | Director |
| James Moe | Director, Executive |
| Jack Pasini | Director, Executive |